L-Leucine benzyl ester hydrochloride is a leucine-derived amino acid ester in which the carboxyl group is converted to a benzyl ester while the amino functionality is present as a hydrochloride salt, retaining the leucine isobutyl side chain. The molecule therefore contains an ester carbonyl and a protonated amino group (as the chloride salt), with stereochemistry corresponding to the L form indicated by the product name. In peptide and amide synthesis workflows, it is used as a protected/activated leucine building block that can be coupled or transformed to introduce the leucine side chain into larger peptide-related intermediates, while the benzyl ester and salt form help control chemoselectivity during stepwise assembly and subsequent deprotection or conversion to carboxylic acid derivatives.
CAT No: CP01324
CAS No:2462-35-3
Synonyms/Alias:2462-35-3;L-Leucinebenzylesterhydrochloride;(S)-Benzyl2-amino-4-methylpentanoatehydrochloride;benzyl(2S)-2-amino-4-methylpentanoatehydrochloride;H-Leu-OBzl.HCl;SCHEMBL1810902;L-Leucinebenzylesterhydrochloride;CTK7D1107;HCYLOEGSAOVRIT-YDALLXLXSA-N;MolPort-003-909-347;1877AB;AKOS016010057;AM81880;MCULE-8357123726;NE10900;AK115644;KB-53294;L-LEUCINEBENZYLESTERHYDROCHLORIDE;SC-09658;FT-0698085;EN300-76958
L-Leucine benzyl ester hydrochloride is an L-configured leucine derivative in which the α-amino group is present as a hydrochloride salt while the α-carboxyl functionality is converted to a benzyl ester. The molecule therefore combines a stereogenic center at the leucine α-carbon with an ester-protected carboxyl group and a protonated amine that can be selectively deprotonated under coupling conditions. The benzyl ester participates in standard ester chemistry and can be removed by hydrogenolysis, enabling downstream access to leucine's free carboxyl group for peptide coupling or further functionalization. The salt form improves handling and can support consistent reactivity in peptide building block preparation and chiral intermediate synthesis workflows.
1. Peptide Synthesis
L-Leucine benzyl ester hydrochloride supports peptide building block preparation in peptide coupling chemistry where leucine's side chain (isobutyl) provides hydrophobic character for sequence design. The hydrochloride salt of the amino functionality can be managed to enable amide bond formation while the benzyl ester protects the carboxyl group from premature activation or side reactions. Benzyl ester deprotection by hydrogenolysis can regenerate the free carboxyl for subsequent coupling cycles or for conversion into other protected amino acid forms. Downstream, the compound can be incorporated into protected peptide fragments, enabling stepwise construction of leucine-containing peptides and peptide analogs used in biochemical research and synthetic methodology development.
2. Chiral Building Block
L-Leucine benzyl ester hydrochloride functions as a chiral amino acid intermediate for stereochemically controlled synthesis of leucine-derived derivatives. The defined L-configuration at the α-carbon provides stereochemical fidelity for downstream transformations that retain the stereocenter, such as ester-to-acid conversion and functional group interconversions at the carboxyl terminus. The benzyl ester offers a removable protecting-group handle that can be carried through derivatization steps requiring temporary carboxyl masking. The resulting leucine scaffold can be used to prepare chiral fragments for peptidomimetic construction, chiral auxiliary-like workflows, and process chemistry intermediate preparation where consistent stereochemical outcomes are required.
3. Side-Chain Functionalization
L-Leucine benzyl ester hydrochloride is applicable to chemical derivatization strategies that target the leucine side-chain chemistry while maintaining a protected C-terminus for controlled coupling. The isobutyl side chain can serve as a hydrophobic element in molecular design and can be further transformed into functionalized leucine analogs through oxidative or substitution-based routes that preserve the protected amino acid termini. The benzyl ester and amine hydrochloride combination enables orthogonal protection logic: carboxyl masking supports selective reactions, while amine deprotonation can be timed for subsequent amide formation. Downstream products can include leucine-based building blocks for SAR studies, peptidomimetic scaffolds, and hydrophobic linker units used in chemical biology and applied synthetic organic chemistry.
4. Pharmaceutical Intermediate Preparation
L-Leucine benzyl ester hydrochloride can be employed in pharmaceutical intermediate preparation where amino acid ester protection and amine salt handling align with scalable fine chemical synthesis practices. The benzyl ester provides a stable carboxyl protection mode during intermediate formation and can be removed to yield the corresponding acid for activation into coupling-ready forms. The leucine backbone, with its stereogenic α-carbon and protected termini, supports conversion into activated derivatives such as acylating agents or protected amino acid variants used in medicinal chemistry synthesis planning. The compound's structural features make it suitable for manufacturing route design that requires predictable protection-group behavior and reliable intermediate interconversion in leucine-containing synthesis sequences.
5. Analytical Standards And Labeling
L-Leucine benzyl ester hydrochloride can serve as an analytical reference material or precursor in analytical research workflows that require a defined leucine derivative with a removable ester group. The hydrochloride salt form and benzyl ester functionality provide distinct chromatographic and spectroscopic signatures that can help in method development for amino acid ester and protected amino acid species. Carboxyl deprotection to the free acid can generate matchable standards for downstream assays that quantify leucine derivatives across synthesis steps. The compound can also be applied as a starting point for isotope-labeling or tracer preparation strategies in which leucine's stereochemistry and protected functional groups must be maintained through labeling and subsequent deprotection to enable downstream analytical or biochemical studies.
1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
2. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.